Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Understanding which assets have the highest returns can guide your investment strategy. Explore various options to enhance your portfolio.
25,689 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Opendoor Technologies stock down discordant headlines have traders wondering if a rebound is possible. This article b...
SVB Capital, a 110-person venture arm once tied to SVB Bank, is in limbo after regulators seized the parent bank. A p...
Want income that compounds over time? These high-yield energy stocks offer reliable payouts and growth potential. Lea...
Investors have been watching does planet labs stock slide for months. This guide breaks down the drivers, the risks, ...
Palantir’s business is booming, yet its stock has struggled. This article breaks down why growth and stock moves aren...
July brought a surprising bounce in the stock market as a major theater chain beat earnings expectations and drew att...
Mortgage rates in early 2026 show a pause after a volatile fall and rise. This piece breaks down what buyers and inve...
Nokomis Capital quietly builds a new position in Apple Hospitality REIT, underscoring a rising appetite for hospitali...
As leveraged ETFs surge in popularity, the active trader dominates turnover in these products, reshaping how markets ...
VSMPX, Vanguard’s ultra-cheap institutional mutual fund share class, mirrors VTI’s exposure at half the price—but ret...
As inflation remains persistent, traders are moving away from speculative growth toward dependable income. Carvana is...